EXTROVIS PRIVATE LIMITED

In their own words

Extrovis is a fully integrated global pharmaceutical company engaged in manufacturing and supply Active Pharmaceutical Ingredients (APIs), Finished dosage forms (FDF) & Custom Pharmaceutical Services. We are supported by strong network to deliver products across geographies. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services. We are engaged in continuous improvement of products and processes to enhance the quality of production and cost competitiveness in order to build value for our customers Our vision stems from our motto - Basic Healthcare Is Our Priority & is built around a desire of not just being the best, but to also be a dependable partner during the development, manufacturing and supply of high-quality pharmaceutical ingredients and finished dosage forms in improve patients’ lives & address unmet medical need. Our mission is to become a reliable partner by offering high quality APIs, FDFs, custom pharmaceutical services and delivering value to our customers, stake holders and patients. Our state-of-the-art manufacturing facilities and R&D centers comply with highest international quality standards with accreditions from the USFDA, PMDA, EU and other global regulatory bodies Our success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products and services across geographies, constantly investing in various growth platforms and promoting a culture of innovation Our progress in diverse businesses has been made possible through the contribution of R&D; for quality, non-infringing process for product development and cost reduction through process innovation. Innovation at Extrovis is backed by strong chemistry, bio science expertise and the knowledge bank created over the years. We have harnessed our strengths – a strong R&D team, modern R&D facilities, command over cheap technologies and economies of scale into a synergistic organic entity, continuously creating and nurturing high quality products and technologies. Backed by our EXTROrdinary VISion, we have our eyes set on becoming a leading pharmaceutical company in the world. Corporate Social Responsibility is an integral part of how Jubilant Life Sciences conducts business and how the efforts are directed towards community development through focus on primary education, basic healthcare service, and livelihood generation programs focused on improving the employability of women and local youth. Our contributions in the area of education and health to financially under privileged reinforces our social commitment We are committed to leverage innovation and scale of operations at every step of the pharmaceutical value chain to deliver value to our stakeholders and patients. Products: APIs: Creating high-quality active pharmaceutical ingredients at competitive prices is one of our core activities at Extrovis. We offer our API portfolio to leading innovator and generic companies across the USA, Europe, Japan, South America, Korea and other emerging markets. We have deep technical strengths in the development of complex APIs including long chain synthesis and fermentation based portfolio. Our expertise in intellectual property, regulatory affairs and strong portfolio strategy & offering enables our customers to be the first-to-market or first-to-file (in the USA). FDFs: At Extrovis we strongly believe in the philosophy of ‘One Global Quality Standard’. Our teams meet or exceed industry standards – conducting ongoing reviews to ensure quality and integrity of products, start to finish, and to continuously improve for optimal quality and consistency. We have strong capabilities and built-in expertise of several decades in taking a portfolio idea to the finish line of regulatory filing and then successful approval, including complex products and unique technologies. Our target geographies are USA, Europe, Japan and the emerging markets. Differentiated Formulations Our differentiated products portfolio aims to fulfil unmet patient needs. We focus on unique drug delivery technologies and drug-device combinations designed to improve the efficacy, safety, compliance as well as bioavailability of drugs where absorption could be limited due to solubility, permeability, and/or stability problems. Currently we have several active developments targeted for filing in USA, Europe and Japan. Solutions for Access Markets At Extrovis we are fully aware and concerned of the challenges governments, healthcare professionals and patients face in diagnosing and treating life threatening illnesses like HIV/AIDS or malaria in the developing countries. We are proud of our efforts to develop and supply high quality and affordable medicines for these markets and committed to make a difference for those in need both by improving efficacy and the ease of use over existing therapeutic options without increasing costs.

Written by the company on its public Startup India profile. Not verified by us.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, use the report link or write to trust@indianstartupmap.com.

How we built this record Where the data comes from How you may reuse it